Found 6 matching trials
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia
PHASE1This phase I trial studies the side effects and best dose of AR-42 when giv...
Location
Cincinnati Children's Hospital
AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
PHASE1RATIONALE: AR-42 may stop the growth of cancer cells by blocking some of th...
Location
The Ohio State University James Cancer Hospital
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
PHASE1This pilot phase I trial studies the side effects and best dose of histone ...
Location
Ohio State University Comprehensive Cancer Center
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
EARLY_PHASE1This will be a multi-center, proof of concept phase 0 study to assess the s...
Location
Stanford University
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
PHASE2This is a two-staged, Phase 2/3, randomized, multi-center study to investig...
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
PHASE1This phase 1 study was developed to identify recommended phase 2 doses (RP2...
Location
Virginia Commonwealth University/Massey Cancer Center